Abstract
Abstract
Decline in mitochondrial function and oxidative phosphorylation in Alzheimer’s disease (AD) are well documented which led us to investigate coordination between mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) genomes specific to oxidative phosphorylation (OXPHOS). Using AMP-AD mtDNA and nDNA datasets, regression analyses of OXPHOS transcriptomic, proteomic profiles and AD clinical biomarkers were conducted. Outcomes revealed that mtDNA and nDNA encoded OXPHOS subunits were negatively correlated at mRNA level while positively correlated at protein level in both cognitively normal and AD brains. However, association between mitochondrial and nuclear OXPHOS transcripts was significantly lower in AD brain. Mitochondrial transcripts were positively correlated with Notch signaling while negatively correlated with synapse formation, bioenergetics, translation, and ubiquitin-related pathways in both control and AD brain. mtDNA- transcript levels were negatively correlated with neuronal cell fractions but positively correlated with oligodendrocyte precursor cell fraction. AD biomarkers, β−amyloid, total tau, and neurofibrillary tangle (NFT) burden, were positively correlated with mtDNA transcript levels. Collectively, our findings reveal altered mitochondria-nuclear genome interactions under AD stress, uncoupled mitochondrial / nuclear genome communication in AD, key role of precursor oligodendrocytes in OXPHOS and AD and suggest coordination between mitochondrial and nuclear genomes regulating OXPHOS as a potential therapeutic target in AD.
Publisher
Research Square Platform LLC
Reference54 articles.
1. Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential;Mi Y;Antioxid Redox Signal,2021
2. A cellular perspective on brain energy metabolism and functional imaging;Magistretti PJ;Neuron,2015
3. Mitochondrial genes are altered in blood early in Alzheimer's disease;Lunnon K;Neurobiology of Aging,2017
4. Nilsen, J. and R.D. Brinton, Mitochondria as therapeutic targets of estrogen action in the central nervous system. Current Drug Targets-CNS & Neurological Disorders, 2004. 3(4): p. 297–313.
5. Yao, J., et al., Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences, 2009. 106(34): p. 14670–14675.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献